Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 101–150 of 159 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05584449	Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors	recruiting	N/A	60	Mayo ClinicOTHER	1	Jan 30, 2026	clinicaltrials
NCT06682039	Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors	completed	N/A	70	Fred Hutchinson Cancer CenterOTHER	1	Jan 30, 2026	clinicaltrials